• bitcoinBitcoin(BTC)$80,290.00-1.21%
  • ethereumEthereum(ETH)$2,570.42-2.68%
  • tetherTether(USDT)$1.00-0.01%
  • binancecoinBNB(BNB)$748.83-2.24%
  • rippleXRP(XRP)$1.38-3.27%
  • usd-coinUSDC(USDC)$1.00-0.01%
  • solanaSolana(SOL)$108.05-3.49%
  • tronTRON(TRX)$0.3423791.43%
  • zcashZcash(ZEC)$1,438.02-6.59%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.02-1.32%
  • HyperliquidHyperliquid(HYPE)$90.81-1.27%
  • dogecoinDogecoin(DOGE)$0.084722-3.74%
  • moneroMonero(XMR)$522.18-10.98%
  • whitebitWhiteBIT Coin(WBT)$81.68-1.77%
  • USDSUSDS(USDS)$1.00-0.01%
  • RainRain(RAIN)$0.013174-5.56%
  • chainlinkChainlink(LINK)$11.99-4.47%
  • cardanoCardano(ADA)$0.219447-2.81%
  • leo-tokenLEO Token(LEO)$8.940.59%
  • stellarStellar(XLM)$0.188990-2.30%
  • uniswapUniswap(UNI)$8.78-3.05%
  • bitcoin-cashBitcoin Cash(BCH)$245.36-2.12%
  • Ethena USDeEthena USDe(USDE)$1.00-0.01%
  • nearNEAR Protocol(NEAR)$3.57-2.57%
  • daiDai(DAI)$1.000.00%
  • litecoinLitecoin(LTC)$56.94-0.54%
  • USD1USD1(USD1)$1.00-0.03%
  • avalanche-2Avalanche(AVAX)$9.765.45%
  • CantonCanton(CC)$0.103553-6.19%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.37-0.01%
  • hedera-hashgraphHedera(HBAR)$0.080241-0.53%
  • suiSui(SUI)$0.81-5.57%
  • MemeCoreMemeCore(M)$1.4410.82%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • shiba-inuShiba Inu(SHIB)$0.000005-2.33%
  • crypto-com-chainCronos(CRO)$0.057703-3.43%
  • BittensorBittensor(TAO)$249.66-7.35%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.02%
  • tether-goldTether Gold(XAUT)$4,369.57-0.09%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • okbOKB(OKB)$115.43-2.99%
  • Ripple USDRipple USD(RLUSD)$1.00-0.02%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.05%
  • aaveAave(AAVE)$135.61-5.87%
  • EthenaEthena(ENA)$0.2030876.07%
  • OndoOndo(ONDO)$0.4101700.69%
  • BitwayBitway(BTW)$0.7322.38%
  • AsterAster(ASTER)$0.73-4.34%
  • mantleMantle(MNT)$0.59-3.16%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

New Assistive Robot Combats Mild Cognitive Impairment

July 9, 2024
in AI & Technology
Reading Time: 4 mins read
A A
New Assistive Robot Combats Mild Cognitive Impairment
ShareShareShareShareShare

Researchers at the University of California – San Diego have introduced CARMEN, a Cognitively Assistive Robot for Motivation and Neurorehabilitation, designed to address the growing challenge of Mild Cognitive Impairment (MCI) in older adults.

MCI affects approximately 20% of individuals over 65, serving as a potential precursor to dementia. With up to 15% of those affected transitioning to dementia annually, the need for effective interventions is critical. While pharmacological treatments have shown limited success in slowing this progression, behavioral approaches offer promising results.

YOU MAY ALSO LIKE

Trump Opposes AI Guardrails Amid Chip Selloff

Anthropic’s Claude Takes Bigger Role in Building AI

CARMEN’s Innovative Approach

CARMEN really stands out and is notable in assistive robotics due to its unique development process and targeted functionality. Unlike many healthcare robots, CARMEN was created through a collaborative effort involving not only researchers but also clinicians, individuals with MCI, and their care partners. This helps ensure that the robot addresses real-world needs and challenges faced by its intended users.

The robot’s primary focus is on teaching compensatory cognitive strategies, a feature that sets it apart from other assistive technologies in this space. These strategies are designed to enhance memory, attention, and executive functioning – key areas affected by MCI. By providing tools and techniques to work around cognitive deficits, CARMEN aims to improve users’ daily functioning and independence.

The development team, led by Professor Laurel Riek, established crucial design criteria to make CARMEN effective for home use.

These include:

  • Independent operation: Users can interact with CARMEN without supervision from clinicians or researchers.
  • Plug-and-play functionality: The robot is designed for easy setup and minimal maintenance.
  • Offline capability: CARMEN can function with limited internet access, ensuring usability in various home environments.
  • Long-term operation: The robot is built for extended use, supporting ongoing cognitive training.
  • Clear communication: CARMEN provides instructions and feedback in an easily understandable manner.
  • Empathy and support: The robot expresses compassion for the user’s situation, fostering engagement.
  • Structured breaks: CARMEN incorporates pauses after challenging tasks to maintain user motivation.

The innovative approach embodied by CARMEN not only addresses the immediate needs of those with MCI but also opens new avenues for home-based cognitive care.

CARMEN in Action

CARMEN’s effectiveness lies in its ability to deliver targeted cognitive training exercises through interactive games and activities. These exercises are designed to teach practical skills that can significantly improve daily functioning for individuals with MCI.

One key strategy CARMEN teaches is the creation of routine places for important objects. For instance, users learn to designate specific spots for items like keys, reducing the frustration and time lost searching for misplaced belongings. The robot also guides users in developing effective note-taking strategies, enhancing their ability to remember crucial information.

These skills are imparted through engaging, interactive sessions. CARMEN’s approach encourages active participation and practice to reinforce learning. This hands-on method helps users internalize strategies, making them more likely to implement these techniques in their daily lives.

Initial home deployments of CARMEN have yielded promising results. The research team placed the robot in the homes of several individuals with MCI for a week-long trial. Participants engaged in multiple tasks with CARMEN, including the aforementioned strategies for object placement and calendar management.

Feedback from these trials was largely positive. Users reported attempting strategies they had previously dismissed as impossible, suggesting CARMEN’s effectiveness in boosting confidence and motivation. Most participants found the robot easy to use and its activities comprehensible, though one user did experience some difficulties. Notably, all participants expressed a desire for more interaction with CARMEN, indicating its potential for sustained engagement.

Future Directions and Implications

Building on these encouraging initial results, the UC San Diego team is planning several enhancements and expanded trials for CARMEN. A key focus is deploying the robot in a larger number of homes to gather more comprehensive data on its effectiveness and user experience.

One significant planned improvement is enhancing CARMEN’s conversational abilities. This development aims to make interactions more natural and accessible, particularly for users who may struggle with touchscreen interfaces. However, the team is mindful of striking a balance – while making CARMEN more conversational, they intend to limit the information it provides to ensure users remain actively engaged in their cognitive exercises.

The potential applications for CARMEN extend beyond MCI. Researchers are exploring how the robot could assist individuals with other conditions, such as ADHD, highlighting its versatility as an assistive technology platform.

As CARMEN evolves, it exemplifies the growing role of robotics in home-based healthcare. By providing consistent, personalized cognitive support, such technologies could significantly impact how we manage cognitive impairment and other neurological conditions.

The development of CARMEN also raises important questions about the future of healthcare delivery. As robots like CARMEN become more sophisticated and widely available, they could help address the growing demand for cognitive care services, particularly in areas with limited access to specialized healthcare professionals.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Trump Opposes AI Guardrails Amid Chip Selloff
AI & Technology

Trump Opposes AI Guardrails Amid Chip Selloff

September 20, 2026
Anthropic’s Claude Takes Bigger Role in Building AI
AI & Technology

Anthropic’s Claude Takes Bigger Role in Building AI

September 20, 2026
Anthropic’s Existential Risk Warnings Hijack Larger AI Debate
AI & Technology

Anthropic’s Existential Risk Warnings Hijack Larger AI Debate

September 20, 2026
Anthropic Investor Franklin: AI Safety Concerns Won’t Slow Spending
AI & Technology

Anthropic Investor Franklin: AI Safety Concerns Won’t Slow Spending

September 20, 2026
Next Post
Maine authorities blame armed standoff on public defender shortage

Maine authorities blame armed standoff on public defender shortage

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Common Problems With Google Wallet And How To Fix Them

Common Problems With Google Wallet And How To Fix Them

September 19, 2026
Chick-fil-A is one of America’s toughest franchises to get — and the startup cost may surprise you

Chick-fil-A is one of America’s toughest franchises to get — and the startup cost may surprise you

September 14, 2026
At least 8 injured in Russian strikes on Kyiv

At least 8 injured in Russian strikes on Kyiv

September 13, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!